Drug Profile
YH 23537
Alternative Names: YH23537Latest Information Update: 18 Oct 2021
Price :
$50
*
At a glance
- Originator Yuhan
- Class Anti-inflammatories; Antirheumatics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Osteoarthritis; Periodontitis
Most Recent Events
- 18 Oct 2021 Discontinued - Phase-II for Osteoarthritis in South Korea (PO)
- 18 Oct 2021 Discontinued - Phase-II for Periodontitis in South Korea (PO)
- 18 Feb 2019 YH23537 is still in phase II trials for Arthritis and Peridontitis in South Korea (Yuhan corporation website, February 2019)